Ebdrup, B H

'No cognitive-enhancing effect of GLP-1 receptor agonism in antipsychotic-treated, obese patients with schizophrenia': authors' response. [electronic resource] - Acta psychiatrica Scandinavica 11 2017 - 526-527 p. digital

Publication Type: Letter; Research Support, Non-U.S. Gov't; Comment

1600-0447

10.1111/acps.12795 doi


Antipsychotic Agents
Glucagon-Like Peptide-1 Receptor
Humans
Obesity
Schizophrenia